首页|补气泄浊汤联合沙库巴曲缬沙坦钠片治疗2型糖尿病肾病脾肾气虚证的临床疗效

补气泄浊汤联合沙库巴曲缬沙坦钠片治疗2型糖尿病肾病脾肾气虚证的临床疗效

扫码查看
目的 观察补气泄浊汤联合沙库巴曲缬沙坦钠片治疗2 型糖尿病肾病(DN)脾肾气虚证患者的临床疗效.方法 将80 例2 型DN患者采用随机数字表法分为2 组,对照组40 例单用沙库巴曲缬沙坦钠片治疗,治疗组40 例予补气泄浊汤联合沙库巴曲缬沙坦钠片治疗,疗程2 个月.比较2 组治疗前后肾功能[尿素氮(BUN)、血肌酐(SCr)、胱抑素C(Cys-C)、β2-微球蛋白(β2-MG)]、24 h尿蛋白定量、炎症细胞因子[白细胞介素 17A(IL-17A)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)]水平及中医证候评分,并统计2 组疗效及药物不良反应率.结果 治疗组总有效率90.0%(36/40),对照组总有效率为 72.5%(29/40),治疗组临床疗效优于对照组(P<0.05).2 组治疗后BUN、SCr、Cys-C、β2-MG、24 h尿蛋白定量均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05).2 组治疗后IL-17A、hs-CRP、TNF-α水平均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05).2组不良反应发生率比较差异无统计学意义(P>0.05).2 组治疗后中医证候各项评分均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05).结论 补气泄浊汤联合沙库巴曲缬沙坦钠片可有效改善2 型DN脾肾气虚证患者的肾功能、尿蛋白、中医证候及临床症状,使IL-17A、hs-CRP、TNF-α水平下降,减少炎症反应.
Clinical efficacy of Buqi Xiezhuo Decoction combined with sacubitril/valsartan on type 2 diabetic nephropathyof spleen-kidney qi deficiency
Objective To investigate the clinical efficacy of Buqi Xiezhuo Decoction combined with sacubitril/valsartan on type 2 diabetic nephropathy(DN)of spleen-kidney qi deficiency.Methods Eighty patients with type 2 DN were randomly assigned in a ratio assigned in a1∶1 ratio to sacubitril/valsartan(control group)or Buqi Xiezhuo Decoction+sacubitril/valsar-tan(treatment group)for 2 months.The aim was to compare renal function(blood urea nitrogen[BUN],serum creatinine[SCr],Cystatin C[Cys-C],β2-microglobulin[β2-MG],24-h urinary protein excretion,inflammatory cytokines[inter-leukin 17A[IL-17A],high-sensitivity C-reactive protein[hs-CRP],tumor necrosis factor-α[TNF-α]),traditional Chinese medicine(TCM)syndrome score.The curative effect and incidence of adverse reactions were assessed.Results The overall effective rate in the treatment group was better than that in the control group(90.0%[36/40]vs 72.5%[29/40],P<0.05).After treatment,BUN,SCr,Cys-C,β2-MG,24-h urinary protein excretion in the both groups were significantly de-creased(P<0.05),which decreased notably in the treatment group compared with the control group(P<0.05).IL-17A,hs-CRP and TNF-α levels in the both groups were significantly decreased(P<0.05),the decrease in the treatment group was more common relative to the control group(P<0.05).None of the incidence of adverse reactions differed significantly between groups(P>0.05).After treatment,TCM symptom scores in the both groups were significantly decreased(P<0.05),which were significantly lower in the treatment group compared to the control group(P<0.05).Conclusion Buqi Xiezhuo Decoction combined with sacubitril valsartan sodium tablets can effectively improve renal function,urine protein,TCM syndrome,decrease IL-17A,hs-CRP,TNF-α levels,and reduce inflammatory response in patients with type 2 DN(spleen-kidney qi deficiency).

Diabetic nephropathyInflammatory responseRenal functionIntegrative medicine

张医春、宋凯

展开 >

山东中医药大学,山东 济南 250014

山东省菏泽市中医医院肾病科,山东 菏泽 274000

糖尿病肾病 炎症反应 肾功能 中西医结合

山东省医药卫生科技发展计划项目

2019W56

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(8)
  • 16